Mapping of genetic deletions on chromosome 3 in colorectal cancer: Loss of 3p25-pter is associated with distant metastasis and poor survival

Annals of Surgical Oncology

Volumn 18, Issue 9, 2011, Pages 2662-2670

  Tsai, Ming Hong ^a,b   Fang, Woei Horng ^c,d   Lin, Shu Hwa ^c,d   Tzeng, Sheng Tai ^c   Huang, Chen Syuan ^c   Yen, Sou Jhy ^a,b   Chou, Shao Jiun ^a,b   Yang, Ya Chien ^c,d  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b CARDINAL TIEN HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CHROMOSOME 3P; CHROMOSOME DELETION; CLINICAL ARTICLE; COLORECTAL CANCER; DISTANT METASTASIS; FEMALE; FLUORESCENCE; GENE INACTIVATION; GENE LOCUS; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE MARKER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; SEQUENCE DELETION; SURVIVAL RATE;

EID: 80052767384     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1603-9     Document Type: Article

References (54)

1. ER Fearon B Vogelstein 1990 A genetic model for colorectal tumorigenesis Cell 61 759 767 2188735 10.1016/0092-8674(90)90186-I 1:CAS:528: DyaK3cXktlyhtrg%3D (Pubitemid 20185636)
2. H el Sebai C Ged F Bonichon H de Verneuil M Longy 1998 Genetic alterations in colorectal cancer, comparative analysis of deletion events, and point mutations Cancer Genet Cytogenet 104 32 38 9648555 10.1016/S0165-4608(97) 00415-9 1:CAS:528:DyaK1cXktlehsL0%3D (Pubitemid 28292822)
3. SD Markowitz MM Bertagnolli 2009 Molecular origins of cancer: molecular basis of colorectal cancer N Engl J Med 361 2449 2460 20018966 10.1056/NEJMra0804588 1:CAS:528:DC%2BD1MXhsFKisr7L
4. JA Meyerhardt RJ Mayer 2005 Drug therapy-systemic therapy for colorectal cancer N Engl J Med 352 476 487 15689586 10.1056/NEJMra040958 1:CAS:528:DC%2BD2MXptlWkuw%3D%3D (Pubitemid 40175974)
5. E Braga V Senchenko I Bazov, et al. 2002 Critical tumor-suppressor gene regions on chromosome 3P in major human epithelial malignancies: allelotyping and quantitative real-time PCR Int J Cancer 100 534 541 12124802 10.1002/ijc.10511 1:CAS:528:DC%2BD38Xlslyjsbo%3D (Pubitemid 34816153)
6. ER Zabarovsky MI Lerman JD Minna 2002 Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers Oncogene 21 6915 6935 12362274 10.1038/sj.onc.1205835 1:CAS:528:DC%2BD38XnsVKrurg%3D (Pubitemid 35221938)
7. S Matsumoto K Minobe Y Utada, et al. 2000 Loss of heterozygosity at 3p24-p25 as a prognostic factor in breast cancer Cancer Lett 152 63 69 10754207 10.1016/S0304-3835(99)00431-0 1:CAS:528:DC%2BD3cXit1Whu7c%3D (Pubitemid 30169019)
8. K Nagao S Yamaguchi H Matsuyama, et al. 2005 Allelic loss of 3p25 associated with alterations of 5q22.3 approximately q23.2 may affect the prognosis of conventional renal cell carcinoma Cancer Genet Cytogenet 160 43 48 15949569 10.1016/j.cancergencyto.2004.11.015 1:CAS:528:DC%2BD2MXltFaqs7k%3D (Pubitemid 40798135)
9. L Roque S Castedo A Clode J Soares 1993 Deletion of 3p25 → pter in a primary follicular thyroid carcinoma and its metastasis Genes Chromosomes Cancer 8 199 203 7509630 10.1002/gcc.2870080311 1:CAS:528:DyaK2cXhtlWjsrw%3D (Pubitemid 23332581)
10. D Lasko W Cavenee M Nordenskjold 1991 Loss of constitutional heterozygosity in human cancer Annu Rev Genet 25 281 314 1687498 10.1146/annurev.ge.25.120191.001433 1:CAS:528:DyaK38Xks1Onu7g%3D (Pubitemid 21903723)
11. MH Tsai WH Fang SW Lin SJ Yen SJ Chou YC Yang 2009 Mitochondrial genomic instability in colorectal cancer: no correlation to nuclear microsatellite instability and allelic deletion of hMSH2, hMLH1, and p53 genes, but prediction of better survival for Dukes' stage C disease Ann Surg Oncol 16 2918 2925 19582509 10.1245/s10434-009-0581-7
12. MH Tsai YC Yang KH Chen, et al. 2002 RER and LOH association with sporadic colorectal cancer in Taiwanese patients Hepatogastroenterology 49 672 677 12063967 1:CAS:528:DC%2BD38XkvFSgsrY%3D
13. A Hirano M Emi M Tsuneizumi, et al. 2001 Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer Clin Cancer Res 7 876 882 11309336 1:CAS:528: DC%2BD3MXjs1els7Y%3D (Pubitemid 32708724)
14. L Deng N Jing G Tan, et al. 1998 A common region of allelic loss on chromosome region 3p25.3-26.3 in nasopharyngeal carcinoma Genes Chromosomes Cancer 23 21 25 9713993 10.1002/(SICI)1098-2264(199809)23:1<21::AID- GCC4>3.0.CO;2-8 1:STN:280:DyaK1cznslOqtw%3D%3D (Pubitemid 28364214)
15. H Kayahara H Yamagata H Tanioka T Miki H Hamakawa 2001 Frequent loss of heterozygosity at 3p25-p26 is associated with invasive oral squamous cell carcinoma J Hum Genet 46 335 341 11393537 10.1007/s100380170069 1:CAS:528:DC%2BD3MXktlekt74%3D (Pubitemid 32524631)
16. A Simsir D Palacios WM Linehan MJ Merino A Abati 2001 Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: utilization of microdissection and polymerase chain reaction in archival tissues Diagn Cytopathol 24 328 332 11335962 10.1002/dc.1070 1:STN:280:DC%2BD3M3jvFyntw%3D%3D (Pubitemid 32411088)
17. S Miyakis T Liloglou S Kearney G Xinarianos DA Spandidos JK Field 2003 Absence of mutations in the VHL gene but frequent loss of heterozygosity at 3p25-26 in non-small cell lung carcinomas Lung Cancer 39 273 277 12609565 10.1016/S0169-5002(02)00506-8 1:STN:280:DC%2BD3s%2FpslKqug%3D%3D (Pubitemid 36279447)
18. F Latif K Tory J Gnarra, et al. 1993 Identification of the von Hippel-Lindau disease tumor suppressor gene Science 260 1317 1320 8493574 10.1126/science.8493574 1:CAS:528:DyaK3sXks12htbc%3D (Pubitemid 23231974)
19. WM Linehan MI Lerman B Zbar 1995 Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer JAMA 273 564 570 7837390 10.1001/jama.273.7.564 1:CAS:528:DyaK2MXksFansLc%3D
20. MJ Nyhan GC O'Sullivan SL McKenna 2008 Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor Biochem Soc Trans 36 472 478 18481984 10.1042/BST0360472 1:CAS:528:DC%2BD1cXmtVKlt7s%3D (Pubitemid 351839358)
21. PG Waber NK Lee PD Nisen 1996 Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer Oncogene 12 365 369 8570213 1:CAS:528: DyaK28XotFSjsQ%3D%3D (Pubitemid 26042572)
22. Z Zhuang MR Emmert-Buck MJ Roth, et al. 1996 von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens Hum Pathol 27 152 156 8617456 10.1016/S0046-8177(96)90368-8 1:CAS:528:DyaK28XhsF2ksLo%3D (Pubitemid 26049468)
23. T Kamura S Sato K Iwai M Czyzyk-Krzeska RC Conaway JW Conaway 2000 Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex Proc Natl Acad Sci USA 97 10430 10435 10973499 10.1073/pnas.190332597 1:CAS:528:DC%2BD3cXms1Crsb4%3D
24. M Ohh CW Park M Ivan, et al. 2000 Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein Nat Cell Biol 2 423 427 10878807 10.1038/35017054 1:CAS:528: DC%2BD3cXkvFCqtrk%3D
25. S Ivanov SY Liao A Ivanova, et al. 2001 Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer Am J Pathol 158 905 919 11238039 10.1016/S0002-9440(10)64038-2 1:CAS:528:DC%2BD3MXitlOnu74%3D (Pubitemid 32221783)
26. MC Maiuri E Zalckvar A Kimchi G Kroemer 2007 Self-eating and self-killing: crosstalk between autophagy and apoptosis Nat Rev Mol Cell Biol 8 741 752 17717517 10.1038/nrm2239 1:CAS:528:DC%2BD2sXpsVartb8%3D (Pubitemid 47312826)
27. LY Xue SM Chiu NL Oleinick 2010 Atg7 deficiency increases resistance of MCF-7 human breast cancer cells to photodynamic therapy Autophagy 6 248 255 20083906 10.4161/auto.6.2.11077 1:CAS:528:DC%2BC3cXot1ehsLc%3D
28. Y Zhao J Yang W Liao, et al. 2010 Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity Nat Cell Biol 12 665 675 20543840 10.1038/ncb2069 1:CAS:528:DC%2BC3cXot1Wmtbc%3D
29. II Wistuba C Behrens AK Virmani, et al. 2000 High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints Cancer Res 60 1949 1960 10766185 1:CAS:528:DC%2BD3cXisVynu7k%3D (Pubitemid 30207657)
30. AL Tai W Mak PK Ng, et al. 2006 High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers Cancer Res 66 4133 4138 16618734 10.1158/0008-5472.CAN-05-2775 1:CAS:528:DC%2BD28XjsFSlt74%3D
31. G Sozzi ML Veronese M Negrini, et al. 1996 The FHIT gene 3p14.2 is abnormal in lung cancer Cell 85 17 26 8620533 10.1016/S0092-8674(00)81078-8 1:CAS:528:DyaK28Xit1aksb4%3D (Pubitemid 26116803)
32. CM Croce G Sozzi K Huebner 1999 Role of FHIT in human cancer J Clin Oncol 17 1618 1624 10334551 1:CAS:528:DyaK1MXjsF2ms7c%3D (Pubitemid 29220872)
33. XP Hao JE Willis TG Pretlow, et al. 2000 Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions Cancer Res 60 18 21 10646844 1:CAS:528:DC%2BD3cXnt1aiuw%3D%3D (Pubitemid 30058722)
34. DL Greenspan DC Connolly R Wu, et al. 1997 Loss of FHIT expression in cervical carcinoma cell lines and primary tumors Cancer Res 57 4692 4698 9354423 1:CAS:528:DyaK2sXnt12gtbg%3D (Pubitemid 27468968)
35. K Huebner CM Croce 2003 Cancer and the FRA3B/FHIT fragile locus: it's a HIT Br J Cancer 88 1501 1506 12771912 10.1038/sj.bjc.6600937 1:CAS:528:DC%2BD3sXktVent78%3D (Pubitemid 36713772)
36. TE Petursdottir SH Hafsteinsdottir JG Jonasson, et al. 2002 Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients Anticancer Res 22 3205 3212 12530066 1:CAS:528:DC%2BD3sXoslygsQ%3D%3D (Pubitemid 36070094)
37. D Angeloni FM Duh MF Wei BE Johnson MI Lerman 2001 A G-to-A single nucleotide polymorphism in intron 2 of the human CACNA2D2 gene that maps at 3p21.3 Mol Cell Probes 15 125 127 11292331 10.1006/mcpr.2000.0341 1:CAS:528:DC%2BD3MXisVKnsLc%3D (Pubitemid 32319956)
38. MI Lerman JD Minna 2000 The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium Cancer Res 60 6116 6133 11085536 1:CAS:528:DC%2BD3cXotV2lsbw%3D
39. GL Carboni B Gao M Nishizaki, et al. 2003 CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity Oncogene. 22 615 626 12555074 10.1038/sj.onc.1206134 1:CAS:528:DC%2BD3sXmslGmuw%3D%3D (Pubitemid 36188618)
40. B Gao Y Sekido A Maximov, et al. 2000 Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2) J Biol Chem. 275 12237 12242 10766861 10.1074/jbc.275.16.12237 1:CAS:528:DC%2BD3cXisl2jtbs%3D (Pubitemid 30237803)
41. A Wanajo A Sasaki H Nagasaki, et al. 2008 Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer Gastroenterology 135 580 590 18588891 10.1053/j.gastro.2008.05. 041 1:CAS:528:DC%2BD1cXhtVCqsLzJ
42. L Shivakumar J Minna T Sakamaki R Pestell MA White 2002 The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation Mol Cell Biol 22 4309 4318 12024041 10.1128/MCB.22.12.4309-4318.2002 1:CAS:528:DC%2BD38XktlSlsrw%3D (Pubitemid 34556598)
43. R Dammann U Schagdarsurengin C Seidel, et al. 2005 The tumor suppressor RASSF1A in human carcinogenesis: an update Histol Histopathol 20 645 663 15736067 1:CAS:528:DC%2BD2MXht1aksbjO (Pubitemid 40468282)
44. M van Engeland GM Roemen M Brink, et al. 2002 K-ras mutations and RASSF1A promoter methylation in colorectal cancer Oncogene. 21 3792 3795 12032847 10.1038/sj.onc.1205466 (Pubitemid 34620542)
45. C Oliveira S Velho E Domingo, et al. 2005 Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer Oncogene. 24 7630 7634 16007118 10.1038/sj.onc.1208906 1:CAS:528:DC%2BD2MXht1WktrzO (Pubitemid 41638038)
46. S Picelli J Vandrovcova S Jones, et al. 2008 Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q BMC Cancer 8 87 18380902 10.1186/1471-2407-8-87 (Pubitemid 351676457)
47. LF Thean C Loi KS Ho PK Koh KW Eu PY Cheah 2010 Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients Genes Chromosomes Cancer. 49 99 106 19847890 1:CAS:528:DC%2BD1MXhsFGjsrjL
48. H Umeto T Yoshida K Araki H Yagishita T Mikami I Okayasu 2009 Appearance of epithelial and stromal genomic instability in background colorectal mucosa of sporadic colorectal cancer patients: relation to age and gender J Gastroenterol 44 1036 1045 19590931 10.1007/s00535-009-0103-1
49. S Lassmann R Weis F Makowiec, et al. 2007 Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas J Mol Med 85 293 304 17143621 10.1007/s00109-006-0126-5 1:CAS:528:DC%2BD2sXhvVehsrY%3D (Pubitemid 46295243)
50. K Nakao KR Mehta J Fridlyand, et al. 2004 High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization Carcinogenesis 25 1345 1357 15001537 10.1093/carcin/bgh134 1:CAS:528:DC%2BD2cXmtF2nsbg%3D (Pubitemid 39162701)
51. XY Xiao XY Zhou G Yan MH Sun X Du 2007 Chromosomal alteration in Chinese sporadic colorectal carcinomas detected by comparative genomic hybridization Diagn Mol Pathol 16 96 103 17525679 10.1097/PDM.0b013e31803190f2 1:CAS:528:DC%2BD2sXmvFGrtr4%3D (Pubitemid 47164742)
52. M Nakao S Kawauchi T Furuya, et al. 2009 Identification of DNA copy number aberrations associated with metastases of colorectal cancer using array CGH profiles Cancer Genet Cytogenet 188 70 76 19100508 10.1016/j.cancergencyto. 2008.09.013 1:CAS:528:DC%2BD1cXhsFamsbjE
53. XP Liu S Kawauchi A Oga, et al. 2007 Chromosomal aberrations detected by comparative genomic hybridization predict outcome in patients with colorectal carcinoma Oncol Rep 17 261 267 17143507 1:CAS:528:DC%2BD2sXhtFagur4%3D
54. K Kurashina Y Yamashita T Ueno, et al. 2008 Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma Cancer Sci. 99 1835 1840 18564138 10.1111/j.1349-7006.2008.00881.x 1:CAS:528:DC%2BD1cXhtFKntbjF